(Q47339288)

English

Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis

scientific article published in January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

0 references

Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Leizorovicz

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

52 Suppl 7

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

30-37

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deep vein thrombosis of the legs: new therapy by means of low molecular weight heparins

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9042557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199600527-00006

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/9042557

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47339288&oldid=2152500359"